Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients with follicular lymphoma

• Max S. Topp,
• Johannes Duell,
• Ana Maria Abajo Guijarro,
• Marielle Odin,
• Tina Nielsen,
• Anand Rajeswaran,
• Michael Wenger,
• Christelle Zundel,
• Aleksandra Bogucka-Fedorczuk,
• Tomasz Wrobel

Affiliations

Max S. Topp

Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany

Johannes Duell

Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany

Ana Maria Abajo Guijarro

F. Hoffmann-La Roche Ltd, Basel, Switzerland

Marielle Odin

F. Hoffmann-La Roche Ltd, Basel, Switzerland

Tina Nielsen

F. Hoffmann-La Roche Ltd, Basel, Switzerland

Anand Rajeswaran

F. Hoffmann-La Roche Ltd, Basel, Switzerland

Michael Wenger

F. Hoffmann-La Roche Ltd, Basel, Switzerland

Christelle Zundel

F. Hoffmann-La Roche Ltd, Basel, Switzerland

Aleksandra Bogucka-Fedorczuk

Department of Hematology, Wrocław Medical University, Wrocław, Poland

Tomasz Wrobel

Department of Hematology, Wrocław Medical University, Wrocław, Poland